Doctor profile · Federal record

Dr. Dmitriy Zak, M.D.

Hematology & Oncology Physician (CMS: Medical Oncology) · Specialist · Hematology & Oncology Physician · Mountain Home, AR

  • NPI 1548371289
  • Accepts Medicare
  • 32 yrs in practice
  • Licensed in 3 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
639 Hospital Dr
Mountain Home, AR 726532914
(479) 587-1700
fax (479) 587-1366

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
January 31, 2024
Year of graduation
1994 — 32 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State licenses (3)
Arkansas #E12161 · New York #2275741 · Alabama #32345

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1548371289. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
149,006
Distinct HCPCS
10
Medicare allowed
$2,723,775
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 30,600 40 $0
J9271 Injection, pembrolizumab, 1 mg 21,000 36 $55
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram 18,540 19 $0
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 12,060 13 $48
J0897 Injection, denosumab, 1 mg 9,540 44 $24
J9264 Injection, paclitaxel protein-bound particles, 1 mg 9,300 11 $13
J9267 Injection, paclitaxel, 1 mg 8,103 21 $0
J1453 Injection, fosaprepitant, 1 mg 7,650 19 $0
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 6,155 61 $0
Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg 3,371 20 $40

In context: peer comparison

Among 5 peers in Mountain Home Hematology & Oncology Physician, average services per provider: 1,521. This provider delivers 98× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,392
Transactions
49
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals Lp 4 $614.54
Janssen Biotech, INC. 10 $130.69
Rigel Pharmaceuticals, INC. 6 $84.89
Daiichi Sankyo INC. 4 $81.48
Puma Biotechnology, INC. 4 $59.61
Merck Sharp & Dohme LLC 3 $49.59
Regeneron Healthcare Solutions, INC. 3 $48.31
Novartis Pharmaceuticals Corporation 3 $44.38
Pfizer INC. 3 $41.03
Abbvie INC. 2 $37.06
Pharmacosmos Therapeutics INC. 2 $28.61
Jazz Pharmaceuticals INC. 2 $26.33
Takeda Pharmaceuticals U.S.A., INC. 1 $17.76
Genzyme Corporation 1 $17.32
Genmab U.S., INC. 1 $14.98

By nature of payment

Food and Beverage
$867
Consulting Fee
$525

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,273
Patients
614
Total drug cost
$115,768
Drug Type Claims Patients Total cost
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 191 75 $6,005
Ondansetron Hcl Generic 122 85 $7,287
Fentanyl Generic 110 29 $9,278
Abrysvo (Rsv Vacc, Pref A and Pref B/Pf) Brand 101 100 $32,446
Anastrozole Generic 100 35 $4,745
Lansoprazole Generic 91 45 $1,397
Acyclovir Generic 78 16 $1,094
Scopolamine Generic 75 38 $9,395
Dexamethasone Generic 66 35 $947
Omeprazole Generic 62 18 $576

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Dmitriy Zak's medical specialty?
Dr. Dmitriy Zak practices Hematology & Oncology Physician in Mountain Home, AR.
Where does Dr. Dmitriy Zak practice?
Dr. Dmitriy Zak practices at 639 Hospital Dr, Mountain Home, AR 726532914. Office phone: 4795871700.
What is Dr. Dmitriy Zak's NPI?
Dr. Dmitriy Zak's National Provider Identifier (NPI) is 1548371289, issued by NPPES.
Does Dr. Dmitriy Zak accept Medicare assignment?
Yes. Dr. Dmitriy Zak accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Dmitriy Zak commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110). Source: CMS Medicare Physician & Other Practitioners file.